La cadena de opciones muestra datos clave de las opciones de acciones de Solid Biosciences a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Solid Biosciences..

Solid Biosciences (NASDAQ:SLDB) Bolsa, Cadena de Opciones

SOLID BIOSCIENCES INC

Solid Biosciences

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

AMPG

AREB

BHAT

BWMN

CALM

DATS

DRIO

EONR

GRFX

HOTH

JBDI

LAES

RGTI

RIME

SANA

SLDB

SVMH

XTIA

Movimientos destacados del premercado: Cal-Maine Foods sube un 3,8%, Sana Biotechnology lidera con un 220,6%.

Las acciones de Cal-Maine Foods suben un 4%; Aquí están 20 acciones que se mueven en el premercado

Solid Biosciences Inc

Solid Biosciences Gains Momentum with Promising DMD Program and Strategic Expansion

Solid Biosciences Inc. Changes to Beneficial Ownership: Cumbo Alexander (Director, President and CEO) (Form4)

Solid Biosciences Inc. Changes to Beneficial Ownership: Hanrahan Jessie (Chief Regulatory Officer) (Form4)

Solid Biosciences Inc. Changes to Beneficial Ownership: Brooks Gabriel (Chief Medical Officer) (Form4)

Solid Biosciences Inc. Changes to Beneficial Ownership: Herzich Paul (Chief Technology Officer) (Form4)

Solid Biosciences Inc. Changes to Beneficial Ownership: Tan Kevin (CFO & Treasurer) (Form4)

Solid Biosciences Inc. Changes to Beneficial Ownership: Howton David T (Chief Operating Officer) (Form4)

Solid Biosciences Inc. Changes to Beneficial Ownership: Ganot Ilan (Director) (Form4)

News

Press Releases

Solid Biosciences to Participate at Upcoming Investor Conferences

Absci

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Aura Biosciences

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

Emergent BioSolutions

Erasca

ETHZilla

Inhibrx Biosciences

Kamada

Kodiak Sciences

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Nanobiotix

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Prothena Corporation plc - Ordinary Shares

Prothena Corp

PureTech Health plc - American Depositary Shares

PureTech Health

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Replimune Group

Regenxbio

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

XOMA Royalty

Y-mAbs Therapeutics

Chardan Capital

JP Morgan

Wedbush

Citigroup

HC Wainwright & Co.

Comments

Solid Biosciences

Solid Biosciences (SLDB) Opciones

Solid Biosciences (NASDAQ:SLDB) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL